Differential expression of tetraspanin CD9 in basal cell and squamous cell carcinomas of the skin and actinic keratosis

Ach,Thomas; Ziemer,Mirjana; Dawczynski,Jens; Strobel,Jürgen; Sauer,Georg; Deissler,Helmut

doi:10.3892/ol_00000006

Differential expression of tetraspanin CD9 in basal cell and squamous cell carcinomas of the skin and actinic keratosis

Authors:
- Thomas Ach
- Mirjana Ziemer
- Jens Dawczynski
- Jürgen Strobel
- Georg Sauer
- Helmut Deissler
View Affiliations

Affiliations: Department of Ophthalmology, University Hospital Heidelberg, Heidelberg, Germany
Published online on: January 1, 2010 https://doi.org/10.3892/ol_00000006
Pages: 37-40

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tetraspanins are potentially useful molecular markers that differentiate between tumour classes and subtypes, since members of this protein family were often found to be altered during malignant conversion and tumour progression. In this study, we analysed expression of the tetraspanin CD9 in the frequent cutaneous neoplasms basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and actinic keratosis (AK), which is considered a precursor lesion (carcinoma in situ) from which an invasive SCC can develop. A moderate to strong CD9-specific staining of the tumour cells' plasma membranes was uniquely observed in all BCCs, SCCs and AKs. All SCCs showed additional intracellular CD9 which was rarely (20%) seen in AKs. Semi-quantitative assessment of CD9 present in the plasma membranes of tumour cells of BCCs (mean staining intensity 1.91) and SCCs (3.64) reflected the different CD9 expression of normal precursor cells from which these tumours most likely originate. Although considered an intermediate stage in the development of SCCs, AKs did not show intense staining of the plasma membranes typical of normal keratinocytes or invasive SCCs (p=0.011) but only moderate intensity (mean 1.63). In BCCs, significantly (p=0.0005, n=56) stronger CD9-specific immunoreactivity was seen in the inner regions of the tumours than at their sites of expansion. In summary, our results point to an important role of CD9 at the front of tumour expansion in BCCs and SCCs, and in the pathogenesis of invasive SCCs.

View Figures

View References

1	Diepgen TL and Mahler V: The epidemiology of skin cancer. Br J Dermatol. 146:1–6. 2002. View Article : Google Scholar
2	Leiter U and Garbe C: Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight. Adv Exp Med Biol. 624:89–103. 2008. View Article : Google Scholar : PubMed/NCBI
3	Frost CA and Green AC: Epidemiology of solar keratoses. Br J Dermatol. 131:455–464. 1994. View Article : Google Scholar : PubMed/NCBI
4	Ortonne JP: From actinic keratosis to squamous cell carcinoma. Br J Dermatol. 146:20–23. 2002. View Article : Google Scholar
5	Kwa RE, Campana K and Moy RL: Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 26:1–26. 1992. View Article : Google Scholar
6	Chin CW, Foss AJ, Stevens A and Lowe J: Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour. J Pathol. 200:308–313. 2003. View Article : Google Scholar : PubMed/NCBI
7	Anthony ML: Surgical treatment of nonmelanoma skin cancer. AORN J. 71:552–558. 5602000.PubMed/NCBI
8	Neville JA, Welch E and Leffell DJ: Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 4:462–469. 2007. View Article : Google Scholar : PubMed/NCBI
9	Jagdeo J, Weinstock MA, Piepkorn M and Bingham SF: Reliability of the histopathologic diagnosis of keratinocyte carcinomas. J Am Acad Dermatol. 57:279–284. 2007. View Article : Google Scholar : PubMed/NCBI
10	Hemler ME: Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 6:801–811. 2005. View Article : Google Scholar : PubMed/NCBI
11	Hemler ME: Targeting of tetraspanin proteins - potential benefits and strategies. Nat Rev Drug Discov. 7:747–758. 2008. View Article : Google Scholar : PubMed/NCBI
12	Scholz CJ, Kurzeder C, Koretz K, Windisch J, Kreienberg R, Sauer G and Deissler H: Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. Cancer Lett. 275:198–203. 2009. View Article : Google Scholar : PubMed/NCBI
13	Si Z and Hersey P: Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer. 54:37–43. 1993. View Article : Google Scholar : PubMed/NCBI
14	Baudoux B, Castanares-Zapatero D, Leclercq-Smekens M, Berna N and Poumay Y: The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol. 79:41–51. 2000. View Article : Google Scholar : PubMed/NCBI
15	Jones PH, Bishop LA and Watt FM: Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun. 4:297–305. 1996. View Article : Google Scholar : PubMed/NCBI
16	Okochi H, Kato M, Nashiro K, Yoshie O, Miyazono K and Furue M: Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin. Br J Dermatol. 137:856–863. 1997. View Article : Google Scholar
17	Sauer G, Windisch J, Kurzeder C, Heilmann V, Kreienberg R and Deissler H: Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin Cancer Res. 9:6426–6431. 2003.PubMed/NCBI
18	Erovic BM, Pammer J, Hollemann D, Woegerbauer M, Geleff S, Fischer MB, Burian M, Frommlet F and Neuchrist C: Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma. Head Neck. 25:848–857. 2003. View Article : Google Scholar : PubMed/NCBI
19	Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M and Imamura M: Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 79:1168–1173. 1999. View Article : Google Scholar : PubMed/NCBI
20	Kusukawa J, Ryu F, Kameyama T and Mekada E: Reduced expression of CD9 in oral squamous cell carcinoma: CD9 expression inversely related to high prevalence of lymph node metastasis. J Oral Pathol Med. 30:73–79. 2001. View Article : Google Scholar : PubMed/NCBI
21	Mhawech P, Dulguerov P, Tschanz E, Verdan C, Ares C and Allal AS: Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Br J Cancer. 90:471–475. 2004. View Article : Google Scholar : PubMed/NCBI
22	Deissler H, Kuhn EM, Lang GE and Deissler H: Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int J Mol Med. 20:643–652. 2007.PubMed/NCBI